**M**embrane proteins have always been attractive, yet challenging subjects in structural biology. Membrane proteins contain specialized domains that are specifically adapted to reside within the hydrophobic environment of the lipid bilayer allowing for the protein to communicate cell signals across the biological membrane. Ion channels are integral membrane proteins that are responsible for movements of ions across the cell membrane and for maintaining the ion concentration gradients within cells, driving numerous physiological processes such as muscle contraction, fertilization, learning and memory. Given the significant role of ion channels in myriad cell functions, knowledge of their high-resolution 3D structures is a critical prerequisite to our understanding of channel functions and molecular mechanisms underlying membrane transport in both normal and disease states.

While membrane proteins are abundant, representing 20-30% of the proteome, high-resolution structures solved for them are disproportionally less, \~2% of unique proteins in the PDB to date, proving them to be more difficult targets than soluble proteins.^[@ref1]^ Hindering efforts to uncover the structures of ion channels is their association with the lipid bilayer, the need to extract them from the membrane, their unwieldy size and often dynamic nature. Large protein size, flexibility and membrane-associated domains make X-ray crystallography or NMR methods difficult to apply for structure determination of full-length membrane proteins. To date, single-particle electron cryo-microscopy (cryo-EM) has emerged as an effective and straightforward approach for the study of membrane protein complexes, their interactions and dynamics in different functional states in a vitrified aqueous solution or lipid environment.^[@ref2]^

Recent advances in cryo-EM technology in combination with continuing developments in image processing software have made it possible to obtain structures of protein complexes beyond 5 Å resolution, with some achieving near-atomic resolutions of 3-4 Å allowing for high-resolution structural models to be derived *de novo* from cryo-EM density maps.^[@ref6]^ Applications of these enhanced technologies by single-particle cryo-EM include protein assemblies within a wide range of molecular weights (\~170 kDa -- \~4 MDa) and complex symmetry.^[@ref14]^ Among recently reported near-atomic resolution structures are a 3.4 Å-resolution structure of the tetrameric TRPV1 ion channel and a 4.5 Å-structure of the γ-secretase, a \~170 kDa membrane-embedded protease, determined by single-particle cryo-EM.^[@ref13],\ [@ref14]^

The ryanodine receptor (RyR), a homo-tetrameric Ca^2+^ release channel, was one of the first non-icosahedral proteins to be solved by single-particle cryo-EM, in part owing to its massive size of 2.3 MDa. However, despite rigorous efforts spent to investigate structure-functional characteristics of RyR channels, there are major gaps in our knowledge about the structure of these ion channels, their ion-conducting pore and modulator-binding sites, largely due to the lack of atomic-level structural details for the entire channel assembly. Several low- to moderate-resolution structures of the full-length channel have been solved and some functional regions mapped to the 3D structure. In addition, atomic models of small soluble portions of the channel have also been determined by X-ray crystallography representing \~10% of the entire protein.

Among the obstacles for achieving a high-resolution structure of RyR channels are its inherent flexibility and location within the biological membrane. RyR ion channels can be conceptualized as integral membrane scaffolding protein assemblies that function in tight association with a large array of multiple intracellular modulatory proteins/ligands, interacting with the channel complex in a dynamic manner to provide specific functional feedback. Thus, obtaining biochemically homogeneous and functionally stable channel protein from its native source *(i.e.* muscle cell) suitable for structure determination by single-particle cryo-EM, remains one of the major challenges in pursuit of a high-resolution structure of the entire RyR channel. Detergents are traditionally used to make membrane proteins water soluble and suitable for X-ray crystallography, NMR or cryo-EM. However, detergents tend to destabilize and inactivate membrane proteins.^[@ref17]^ While single-particle cryo-EM remains the most viable methodology for structural analysis of large membrane protein complexes such as RyRs, the presence of detergent in the buffer is an impediment to producing high-resolution cryo-EM structures of membrane proteins. This review will focus on the structure determination of the Ca^2+^ release channel by single-particle cryo-EM with an emphasis on cryospecimen preparation. We will discuss how the choice of surfactant may affect cryospecimen preparation and the success of cryo-EM imaging of membrane proteins.

Ryanodine Receptor Biology -- From Discovery to Structure {#sec1-1}
=========================================================

The ryanodine receptor is an intracellular Ca^2+^ release channel that resides in the sarcoplasmic reticulum (SR) membrane and is integral to the Ca^2+^ dependent signaling process of muscle contraction. In skeletal muscle, type 1 RyR (RyR1) forms a macromolecular complex with voltage-gated Ca^2+^ channels, Ca~V~1.1, located in the adjacent T-tubule membrane, whereby Ca~V~1.1 senses membrane depolarization and transmits a mechanical signal to RyR1 resulting in the release of Ca^2+^ ions from SR stores through RyR1. The voltage-mediated rapid release of Ca^2+^ into the cytosol from SR stores allows for the contractile apparatus to operate, a process called excitation-contraction coupling. Excitation-contraction coupling in cardiac muscle differs in that the voltage sensor is not physically coupled to the Ca^2+^ release channel, instead, coupling relies upon Ca^2+^ entry through the Ca~V~1.2 channel to initiate type 2 RyR (RyR2) openings. Disruption of excitation-contraction coupling can result in several pathological consequences. Mice lacking RyR1 or RyR2 protein expression die either prenatally or perinatal.^[@ref18],[@ref19]^ Mutations in the RyR channel protein can cause abnormal Ca^2+^ handling and lead to several conditions in humans including Malignant Hyperthermia, Central Core Disease, Multi-minicore Disease, catecholaminergic polymorphic ventricular tachycardia and arrhythmogenic right ventricular cardiomyopathy.^[@ref20]^ Structure-function studies of RyR to date have been conducted in the absence of high-resolution information about the molecular arrangement of the channel, yet this level of information is necessary to understand the molecular basis for excitation-contraction coupling and channel dysfunction.

The RyR channel functions as a homotetrameric channel with a total molecular mass of 2.3 MDa, each monomer containing \~5000 amino acids. The channel consists of a large cytoplasmic N-terminal region (\~80% of the protein mass), several membrane-spanning segments and a small cytoplasmic C-terminus. The *N*-terminal domain serves as a scaffold for many regulatory proteins and molecules to bind, including Ca^2+^, ATP, caffeine, Mg^2+^, PKA, ryanodine, calmodulin, FK506 binding protein and Ca~V~1.1. The transmembrane region of RyR contains the ion-conducting pore across the SR membrane, and based on sequence analysis the channel is predicted to contain an even number of membrane spanning helices per subunit, likely between 4 and 12, encompassed within the amino acid sequence 3985-4940.^[@ref21]^ However, the exact number of transmembrane helices has yet to be confirmed by direct structural analysis of the channel. Three mammalian isoforms of RyR exist (RyR1-3) and have a relatively high amino acid sequence homology (\~65%). Divergent sequences between the three isoforms occur in domains known as D1 (residues 4254-4631 in RyR1), D2 (residues 1342-1403) and D3 (residues 1872-1923) and are likely responsible for the differences in regulation by the channels. RyR1 is predominantly expressed in skeletal muscle; RyR2 is predominantly expressed in cardiac muscle, and RyR3 is found in brain and diaphragm. None of the isoforms are completely tissue specific, although, RyR1 is the most thoroughly studied isoform due to its abundance in fast-twitch skeletal muscle and relative ease of purification.

The first visual documentation of RyR1 occurred over 40 years ago where RyR1 was identified using thin-section electron microscopy as a large "foot" structure spanning the gap between skeletal muscle T-tubule and SR membranes ([Fig. 1](#fig001){ref-type="fig"}).^[@ref25]^ Initially, the composition and role of the foot structure was unclear until biochemical isolation and characterization led to its identification as the Ca^2+^ release channel, which was greatly facilitated by the protein's ability to bind the plant alkaloid ryanodine with high affinity and specificity.^[@ref26]^ Early studies on purified single channels by electron microscopy provided a snapshot into the channel ultrastructure and basic quaternary features, followed by the first 3D reconstruction of negatively stained channel particles determined to \~40 Å resolution.^[@ref32],[@ref33]^ These studies paved the way for determining the structure of the detergent-solubilized RyR1 under frozen, hydrated conditions by cryo-EM. Extensive efforts have been made to study the 3D structure of the detergent-solubilized RyR1 by using electron microscopy of both single particles^[@ref34]^ and 2D crystals.^[@ref42]^

The first structures of RyR1 by single-particle cryo-EM were generated for the 'closed' Ca^2+-^depleted state by two different groups to \~40 Å resolution elucidating its now characteristic mushroom-shape appearance^[@ref34],[@ref36]^ The general structure of the RyR1 channel exhibits 4-fold symmetry with an overall square-mushroom shape top (280 Å × 280 Å × 120 Å) connected to a stalk structure (120 Å × 120 Å × 60 Å) ([Fig 2](#fig002){ref-type="fig"}). Much of RyR1's mass is contained in the cytoplasmic domain and is connected to the transmembrane domain through the stalk structure that is composed of four column domains and rotated \~40° with respect to the cytoplasmic domain. The cytoplasmic region contains several cavities and globular sub-regions with highly flexible clamp-shaped structures present at the corners. Structures of the RyR2 and RyR3 isoforms determined by cryo-EM have an overall architecture similar to that of the RyR1 channel.^[@ref43]^ The cytoplasmic portion of RyR1 serves as a scaffold for many of the channel regulators. Several domains^[@ref46]^,^[@ref47]^,^[@ref50]^ and modulator binding sites (e.g. FKBP12, calmodulin, imperatoxin A have been mapped to the 3D structure of the channel.^[@ref51]^ While these structures were determined at low resolutions, they have provided an abundance of information concerning the regulation of the channel. Moreover, in cases where the binding/regulatory sequences are known, localization allows for the assignment of sequence to the 3D structure.

Conformational changes associated with RyR1 channel opening were also addressed by cryo-EM. Based on biochemical and electrophysiological studies, RyR channel gating can be controlled by the presence of Ca^2+^, adenine nucleotides and ryanodine. The addition of channel activators to the RyR1 cryospecimen permitted samples to be driven into a channel 'open' state, allowing for the investigation of the molecular motions associated with several states of channel gating.^[@ref54]^,^[@ref55]^ These studies detailed the first direct evidence of the channel's long-range structural changes under activating conditions revealing general allosteric mass rearrangements that occur with channel gating. At \~30 Å resolution the RyR1 structure exhibited a global conformational change, opening of the cytoplasmic clamp domains, mass depletion and a 4° twist of the transmembrane domain, twisting like the iris of a camera.^[@ref54],[@ref55]^

Our current knowledge of RyR1's structure has progressed from a rather hollow appearing cytoplasmic domain nested atop a dense stalk containing the transmembrane domain to moderately high resolution structures where some secondary structure features are detectable, domain and subunit boundaries are more clearly distinguishable and a putative pore region is described. From the initial data set by Serysheva *et al.*^[@ref36]^ algorithmic improvements in image processing correcting for microscope aberrations using CTF correction resulted in a 14 Å resolution map of RyR1^[@ref38]^ ([Fig. 2](#fig002){ref-type="fig"}, left). The improved map exhibited more structural detail and allowed for generation and fitting of a homologous structural model for the RyR1 *N-*terminal domain (residues 216-572) within the clamp region.

The arrangement of α-helices in the transmembrane domain were still ambiguous in the 14 Å resolution density map of RyR1, however, two groups achieving 10.2 Å and 9.6 Å resolution structures ([Fig. 2](#fig002){ref-type="fig"}, middle and right) of the Ca^2+^-depleted state of RyR1 resolved 5-6 α-helices in the transmembrane and pore domains including a horizontal helix and a putative pore helix at the luminal side of the channel.^[@ref37]^,^[@ref39]^,^[@ref40]^ Comparison of the Samso *et al.* structures of the closed and open states indicated that the inner helices kink in order to widen the pore allowing ions to pass through the membrane.^[@ref41]^ Whereas the Ludtke *et al.* structure showed that the inner helices were already kinked in the closed state.^[@ref37]^ Subtle differences in handling the protein, such as freeze-thawing the sample prior to vitrification, cryospecimen preparation or imaging conditions may be at the root of such ambiguity, and higher resolution structures are ultimately necessary to address the transmembrane domain helical arrangement and gating mechanism. Furthermore, modeling of ion permeation pathway of the RyR channels has substantially advanced our understanding of RyR1 gating and ion conduction.^[@ref99],[@ref100]^ While these studies are highly important and combine vast research data on RyR function and based primary on available high-resolution crystal structures of the KcsA/KvAP/Shaker channels, they are out of scope of this review and will not be discussed here.

Although all of the previous studies used conventionally accepted methods for resolution determination, currently a more stringent estimation of resolution via the 'gold standard' method has now been adopted by the cryo-EM field making the highest resolution maps currently available for RyR1 more appropriately estimated at \~12-15 Å resolution.^[@ref56]^,^[@ref57]^ It is also critical that as cryo-EM produces higher resolution structures that these maps be evaluated for the resolvability of features at the claimed resolution whereby α-helices should appear as rod-like densities at \~9 Å and a helical pitch detectable at \~6-7 Å resolution; β-sheets should appear as planar density at 8-9 Å resolution and strand separation should occur at \~5 Å resolution or better; connectivity between structural features should be identifiable at \~6 Å resolution or better and at \~4 Å resolution bulky side chain densities will begin to appear and the path through the density should be clearly resolved.^[@ref57]^,^[@ref58]^

Prior to any soluble domains of the RyR1 channel solved by X-ray crystallography, bioinformatics and density-constrained comparative modeling were utilized to generate a homology model of the RyR1 N-terminal domain (residues 12--572) based on its high structural homology to the N-terminus of the IP3 receptor, which contains the IP~3~ binding and suppressor domains.^[@ref39]^ This model was later confirmed by X-ray crystallography of the RyR1 *N*-terminus. The *N*-terminal structure contains three domains composed of two β-trefoil structures (residues 1--205 and 206--394) followed by a bundle of five α-helices (residues 395--532).^[@ref59]^ While structurally similar to the IP~3~ binding domain, RyR1 channel cannot bind or be regulated by IP^[@ref3]^. However, over 30 disease-associated mutations are found in the RyR1 *N*-terminal domain that are proposed to affect channel function by protein misfolding or destabilization of inter- and intra-domain interactions. Fitting of the X-ray structure into the RyR1 cryo-EM density maps yielded two feasible locations, one in the clamp domain and one in the central cytoplasmic vestibule.^[@ref39],[@ref59]^

A structural model of an additional functional domain of the channel was determined by X-ray crystallography for RyR1 residues 2734-2940, which contains 11 disease-associated mutations and a PKA phosphorylation site.^[@ref60]^ The domain is a two-fold symmetrical structure with each half containing two α-helices, one or more short 310 helices and a *C*-terminal β-strand with the halves separated by a long, flexible loop containing the phosphorylation site. This structure was computationally fitted into the clamp domain of the cryo-EM 3D structure of the tetrameric RyR1 channel.^[@ref60]^ However, caution should be used when docking small domains into very large density maps.^[@ref61]^ At intermediate resolutions (coarser than 1 nm), secondary structure elements are marginally detectable and remain unresolved in a majority of protein densities, resulting in too little structural information to anchor and unambiguously validate fits. In this situation, the validity of the X-ray model fit-to-density is limited by the resolution of the cryo-EM density map and the low resolvability of features in the map can leads to an imperfect match. It is clear that a sufficiently high-resolution cryo-EM map of the full-length channel (\<1 nm resolution based on the gold standard criteria), such that secondary structures become better resolved, is required to reconcile the placement of domains and to provide a structural context for RyR1 function. While the current state of the art technology is available for producing near-atomic resolution structures using cryo-EM, cryospecimen preparation is now, more than ever, key to achieving improved resolution density maps for RyR1.

Cryo-EM Imaging of Membrane Proteins in Detergents {#sec1-2}
==================================================

Due to recent technical advances in the cryo-EM field, the achievable resolution for membrane proteins is now 3-7 Å,^[@ref13],[@ref14],[@ref62]^ however vitrification of membrane protein samples is a critical rate-limiting step. In single-particle cryo-EM, the sample is preserved in a layer of vitreous ice and visualized in the form of isolated unordered particles. In general, to achieve a 3D structure using single-particle cryo-EM, the object that is vitrified must be monodisperse in solution and exhibit random orientations. A 3D reconstruction can be obtained through image processing by combining of thousands of 2D projection images of the 3D object being imaged. Integral membrane proteins naturally reside in a lipid bilayer satisfying the hydrophobicity of their transmembrane domain. Thus, to achieve vitrification conditions for cryo-EM visualization, membrane proteins are extracted from their native membrane environment and imaged in detergent-bound forms in aqueous solution.^[@ref17]^ However, the loss of the structural support provided by the native membrane environment can lead to destabilization and inactivation of membrane proteins, which contributes a significant barrier to membrane protein research in general.^[@ref63]^ Moreover, cryo-EM studies confront the additional hurdle of the presence of detergent in the sample, that can prevent the particles from being distributed evenly in the embedding ice and dramatically reduce the image contrast critical to producing reliable and high-resolution cryo-EM reconstruction.^[@ref64]^

Single-particle cryo-EM studies of membrane proteins are substantially reliant on the successful solubilization and purification of monodisperse, isotropic solutions of the target protein. Integral membrane proteins exhibit a complex distribution of surface charges where the hydrophobic transmembrane domains are separated by intervening hydrophilic regions that are typically exposed into aqueous intra- or extra-cellular environment. Thus, membrane proteins extracted from their membranous environment will not be water-soluble unless they are placed in a surrounding environment compatible with their hydrophobicity. Due to their amphipathic nature, detergents allow for the removal of membrane proteins from a lipid environment while maintaining their solubility in aqueous solution. Detergents bind to hydrophobic transmembrane domains of membrane proteins and form an amphipathic belt, solubilizing the protein and substituting for the lipid bilayer.^[@ref17]^ These detergent belts are in rapid equilibrium with free detergent monomers and detergent micelles. Thus, the molecular properties and physical behavior of the detergent in the form of micelle and protein-detergent complexes are critical parameters to be considered and controlled in determining the success of single-particle cryo-EM experiments.

The primary difficulty encountered in the single-particle cryo-EM study of detergent-bound membrane proteins is preparation of cryospecimen with particles being evenly distributed within a thin layer of vitreous ice. In general, vitrification of proteins depends on environmental conditions such as temperature, humidity, buffer composition, pH, ionic strength, and surface properties of a supporting film on EM grid. While recent development of semi-automated devices have significantly improved the search for optimal conditions for ice-embedding, the presence of detergent in the membrane protein sample adds to the complexity of the system by changing the surface properties of its components. The presence of detergent in solution reduces the surface tension of the buffer making it difficult to obtain uniform ice film with evenly distributed vitrified particles of membrane protein. Particles that do not adhere to the grid or form a narrow peripheral band close to the edge of the hole in the cryospecimen is a common obstacle in single-particle cryo-EM studies of membrane proteins. This is disadvantageous to cryo-EM data collection since imaging fields often yields only few membrane protein particles per frame. To overcome this difficulty, a continuous carbon film is often used to improve adhering particles to the EM grid (reviewed in^[@ref65]^). However, in the presence of carbon supporting film, the RyR1 channel particles exhibit a strong preferred orientation with a majority of particles appearing along the four-fold channel axis. While oblique views are certainly present within the cryospecimen and can be retrieved via iterative image processing procedure,^[@ref36]^ their presence is highly variable and specimen dependent. It requires a collection of substantially larger data sets to bring these oblique views to statistical significance in order to achieve reliable isotropic reconstruction of RyR channels.

Another difficulty in cryo-EM study of membrane proteins is that the presence of detergent in the cryospecimen substantially reduces signal to noise ratio in EM images, which is already considered very low for single-particle studies. This effect is particularly disastrous for the high-resolution signal where contrast is marginal even without detergent. For optimal stability of protein-detergent complexes, detergent concentrations are kept near or above the critical micelle-forming concentration (CMC), meaning the buffer is nearly saturated with detergent molecules, which produces a tremendous level of 'noise' in cryo-EM images and can reduce image contrast. This is by far a limiting aspect of cryo-EM visualization of membrane proteins in detergent. This point has not been widely understood in the cryo-EM community since the detergent also produces very strong Thon rings, giving such images an appearance of very good quality when judged by its power spectrum. While there is no accepted standard for assessing a minimal acceptable contrast level in the raw cryo-EM images, it is evident that as contrast is reduced, image processing becomes more susceptible to a model bias and producing a reliable 3D reconstruction becomes problematic.^[@ref64]^

Clearly, the physical behavior of detergents and properties of protein-detergent complexes must be considered and controlled during cryo-EM experiments. However, despite the increasing number of structures of membrane proteins solved by single-particle cryo-EM, ice-embedding procedure for membrane proteins remains most difficult due to the lack straightforward, reproducible methodologies and strategies. The choice of the detergent chosen for the disruption of lipid bilayer and extraction of the membrane protein of interest is rather more empirical than knowledge-driven procedure. In light of the complexities of protein-detergent interactions, it is important to preserve structure and function of membrane proteins while maintaining their solubility. However, no 'magic bullet' detergent exists for handling all membrane proteins in a manner suitable for single-particle cryo-EM experiments, and often trial-and-error is the only way to tell. Examples of successful single-particle EM studies of ion channels and some other integral membrane proteins are given in [Table 1](#table001){ref-type="table"}. Despite the fact that critical information on vitrification of membrane proteins is unpublished, bits of lore can be extracted from these studies to rationalize cryo-EM experiments with membrane proteins. The general conclusion is that detergents with low CMC and high aggregation number are often not compatible with single-particle cryo-EM ([Table 2](#table002){ref-type="table"}). Through our experiences with membrane proteins and cryo-EM we found that single-particle cryo-EM experiment should be performed at or just below CMC to improve adhesion of membrane protein particles within a layer of vitreous ice on the EM grid yet maintain a soluble membrane protein. Having too little detergent in solution can shift the equilibrium to favor detergent monomers over micelles, leading to unprotected transmembrane domains and protein aggregation while, too much detergent may dissociate some stabilizing lipids required to maintain the protein's structure and affect ice-embedding procedure. Overall, selection of the appropriate detergent for the study of membrane protein by single-particle cryo-EM requires the consideration of how it will impact the protein activity, quaternary structure and its propensity for vitrification. The limited current understanding of protein/detergent systems and forces that maintain the sample in a vitreous ice have frustrated efforts of many researches to exploit the structure of membrane proteins using single-particle cryo-EM and stimulated the developments of approaches to transfer membrane proteins to a more tractable environment that would satisfy the hydrophobic nature of the transmembrane domains and allow for reproducible successful vitrification^[@ref5],[@ref66]^ Alternatives to maintaining membrane proteins in non-detergent aqueous solutions, like amphipols, have begun to prove useful in cryo-EM.

Imaging of Membrane Proteins in Detergent-free Aqueous Solution {#sec1-3}
===============================================================

To circumvent detergent-imposed difficulties in single-particle cryo-EM studies of membrane proteins, amphipols (Apols) have recently been adopted in cryospecimen preparation with much success. Cryo-EM structures of Apol bound TRPV1 channel and **γ**-secretase complex were solved at 3.4 Å and 4.5 Å, respectively, resolving their transmembrane domains at resolutions where the cryo-EM density maps served as the basis for generating *de novo* molecular structures. ^[@ref13],[@ref14]^ The use of Apols allows for a detergent-free approach to maintain membrane protein complexes in solution and provides several benefits for attaining high-resolution structures by single-particle cryo-EM.

Apols are a new class of amphipathic polymers that are designed to substitute for detergents, keeping membrane protein complexes soluble and functional in aqueous solution.^[@ref69]^ Apols are considered more mild surfactants than detergents and exhibit a very high affinity for transmembrane surfaces due to a large number of hydrophobic chains. Apols interact non-covalently forming a protective belt around the transmembrane domain, and yet they bind almost irreversibly in the absence of detergent (≥ CMC) and have an exceedingly low rate of spontaneous desorption.^[@ref72]^ However, Apols are weak membrane solubilizing surfactants and detergents are still necessary to extract membrane proteins from the lipid membrane. Detergents can easily be exchanged for Apols and removed from solution allowing for the membrane protein to be in a milder detergent-free aqueous environment while preventing protein aggregation and preserving protein structure-function stability.69-71 Membrane proteins are structurally flexible by the very nature of their function, which can often be a detriment to producing a structurally homogenous sample. Apols have been shown to stabilize transmembrane domains and require virtually no excess solution concentration once they have been substituted for detergent.^[@ref70]^,^[@ref73]^ Based on these favorable properties, Apols are a promising option in the pursuit of membrane protein structures by cryo-EM.

Amphipol 8-35 (A8-35), one of the most well-characterized Apol, appears to be particularly amenable for single-particle cryo-EM studies of ion channels.70 Our group initiated studies of RyR1 in complex with A8-35, a highly water-soluble derivative of polyacrylic acid.^[@ref70],[@ref76],[@ref77]^ In cryo-EM studies, trapping detergent-solubilized RyR1 with A8-35 allowed reproducibility to vitrify RyR1 channel within the holes of a holey-carbon grids with particles well dispersed throughout the ice ([Fig. 3A,B](#fig003){ref-type="fig"}). Our initial studies of the vitrified RyR1/A8-35 complex showed a strongly preferred particle orientation, similar to RyR1 protein frozen on supporting continuous carbon-film. The mechanism behind why RyR1 adopts a preferred orientation in comparison to other membrane proteins, like the IP3R channel, is unknown, however, RyR1's complexity of surface charges combined with its awkward organization in 3D space due to its enormous cytoplasmic domain (\>80% of protein mass) likely play a role in driving the preferred orientation. Furthermore, in the presence of A8-35, we believe that the polymer forms a negatively charged film at the water-air interface during sample application to the EM grid resulting in channel particles in a preferred orientation. The addition of octyl-glucoside (OG) in a concentration 10 times below its CMC resulted in a random distribution of channel particles that we believe is caused by OG disrupting the polymer film ([Fig. 3C](#fig003){ref-type="fig"}). Detergents below their CMC remain as monomers in solution and do not disrupt the Apol/membrane protein complex and no significant loss of signal was observed.^[@ref72]^ Similar approaches for adding small amount of detergent have been used in other imaging projects to reduce preferred orientation.^[@ref7]^ Another approach is the use of short-chain phospholipids, such as DHPC, that are believed to not strongly interact with the membrane protein but can form a monolayer at the air-water interface to reduce surface interactions with the Apol.^[@ref78],[@ref79]^ Such monolayers represent a very low volumetric concentration and should not have any significant impact on image contrast.

Increased image contrast in the presence of Apol is particularly critical in the pursuit of high-resolution structures of membrane proteins in general. In cryo-EM images of Apol bound RyR1, the background observed is dramatically lower than in images with detergent present. The Apol bound RyR1 data has \~2-6% contrast at 5-10 Å resolution as compared to 0-2% in the presence of CHAPS using a traditional CCD detector. Advancements in cryo-EM imaging detectors have led to an increased contrast in at high to intermediate resolutions and are one of the reasons the field is seeing an increase of near-atomic resolution structures solved by cryo-EM. With new technology in place, a more stabilized protein with higher image contrast in detergent-free solution will greatly benefit the structural studies of the RyR1 channel complex.

In order to address the structure-function relationship using cryo-EM, it is important that proteins are assessed for their functionality in solution, when possible. We have tested the functionality of RyR1/A8-35 complexes by \[^[@ref3]^H\]-ryanodine binding assay, which yielded a Kd of 1.99 nM and Bmax of 60.4 pmol/mg, similar to that of purified RyR1 in the presence of 0.4% CHAPS ([Fig. 4](#fig004){ref-type="fig"}).^[@ref80],[@ref81]^ Since, ryanodine binds specifically and with high affinity preferentially to the open state of the intact RyR1 channel, this radioligand binding assay can be considered as an indirect measure of channel activation and indication of its tetrameric structure.^[@ref30]^

It is evident by recent structural studies by cryo-EM that Apols have a major advantage in stabilizing membrane proteins in aqueous solution, reducing detergent-based background in cryo-imaging and maintaining functionality. Determining the structure of many challenging membrane proteins, like the Ca^2+^ release channel, by cryo-EM will no doubt be well served by detergent alternatives like Apols.

Future outlook {#sec1-4}
==============

While much progress has been made in the elucidation of the structure of RyR1 by cryo-EM and X-ray crystallography, there is still a need to pursue atomic level resolution structures of the channel in order to fully understand channel function. Cryo-EM and image processing technology, with their continuing advancements, are in their prime to be able to produced atomic-level details in density maps that can be directly utilized for *de novo* model building. Cryospecimen preparation, especially for membrane proteins, now appears to be a major bottleneck in the cryo-EM experiment. It is a formidable challenge to produce biochemically homogeneous and structurally stable large membrane protein complexes like the Ca^2+^ release channel and is compounded by the structural flexibility inherent to RyRs complex allosteric regulation. The successful use of detergent alternatives, like Apols, will undoubtedly energize the field of the membrane protein structural biology by cryo-EM. The momentum in single-particle cryo-EM is currently remarkable and near-atomic resolution structures of the entire Ca^2+^ release channel should be expected in near future.

Note added at proof {#sec2-1}
-------------------

*While this review was in press, three new cryo-EM structures of RyR1 were deposited to EM Data Bank (EMDB ID: 2751, 2752, 6106, 6107 and 2807). The structures were determined at 4.8-8 Å resolutions based on the "gold-standard" criteria.*^[@ref56]^
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![Timeline summary of RyR1 structural studies.\
RyR1 was first identified as large electron-dense "foot" observed between the junctions of T-tubule and SR membranes.^[@ref25]^ Over the next two decades many efforts were made to molecularly identify the structure observed in the triad junctions and its role in muscle physiology.\
Eventually, through the use of ^[@ref3]^H-ryanodine, differential centrifugation and biophysical characterizations, RyR1 was solidified as the intracellular Ca^2+^ release channel responsible for the release of Ca^2+^ preceding muscle contraction.^[@ref27]^ Due to its relative ease of purification and large size, the structure of RyR1 was investigated by single-particle electron-microscopy. The first 3D structure was obtained by negative stain microscopy, reveling basic morphological features, albeit in a stained and dehydrated state.^[@ref33]^ The first depictions of RyR1 in the more native, hydrated conditions came \~4 years later by cryo-EM and were solved to \~30 Å resolution.^[@ref34],[@ref36]^ Low-resolution structural dynamics of RyR1 gating were described by adding ligands that affect channel open probability to the cryospecimen prior to virtification.^[@ref54],[@ref55]^ Several additional low-resolution structures of RyR1 were solved that localized small molecule binding sites (CaM, FKBP12 and imperatoxin) and functional domains on the 3D structure of RyR1.^[@ref46],[@ref47],[@ref50]^ Structures of RyR2 and RyR3 isoforms were also determined by cryo-EM and appear similar in nature to RyR1. ^[@ref43],[@ref45]^ In two decades since the first structure of RyR1 by cryo-EM was determined, \~1 nm resolution structures were obtained and density based models of channel gating were proposed.^[@ref37],[@ref40]^ Homology models for the N-terminal domain of the channel were created based on structures of the IP^[@ref3]^R1 N-terminus and computationally fitted to the map ^[@ref38],[@ref39]^ Several secondary structure elements in the cytoplasmic and transmembrane domains and subunit boundaries were detectable resulting in a molecular model for some transmembrane helices. Gating induced structural changes were investigated in a \~1 nm resolution structure.^[@ref41]^ Structural models for three disease hot-spot domains were determined by X-ray crystallography: the RyR1 N-terminal domain (residues 1-559; PDB: 2XOA), phosphorylation domain (residues 2734-2940; PDB: 4ERT) and SPRY2 domain (residues 1070-1246; PDB: 4P9I, 4P9J, 4P9L).^[@ref59],[@ref60],[@ref82],[@ref98]^ With state of the art imaging technology in place, the future for the Ca^2+^ release channel is ripe to proceed towards near-atomic resolutions.](ejtm-2015-1-4803-g001){#fig001}

![3D structures of the tetrameric RyR1 channel determined by cryo-EM.\
Surface representations of RyR1 density maps by single-particle cryo-EM viewed in three orthogonal views -- from cytoplasm (top), along the membrane plane (middle) and from luminal side (bottom) of the membrane. Left to right are RyR1 density maps at 14 Å (EMD-1274), 10.2 Å (EMD-5014) and 9.6 Å (EMD-1275) resolutions.^[@ref37],[@ref38],[@ref40]^](ejtm-2015-1-4803-g002){#fig002}

![Cryo-EM images of ice-embedded purified RyR1: in the presence of 0.4 % CHAPS (A) in the presence of A8-35 (B); in the presence of A8-35/n-octyl glucoside \[OG\]. Note preferred orientation of RyR1 particles in (B), while the particles are randomly oriented within the vitreous ice due to achieved optimal protein/Apol8-35/OG ratio in the cryospecimen shown in (C). Images were recorded on a Gatan 4k x 4k CCD camera using JEM2010F cryomicroscope operated under minimal electron dose conditions (\~20 ^e^-/Å^[@ref2]^).\
Scale bars are 500 Å.](ejtm-2015-1-4803-g003){#fig003}

![Scatchard analysis of \[^[@ref3]^H\]-ryanodine binding to RyR1: in skeletal muscle SR membranes (•), purified RyR1 bound to CHAPS (▲) and 800 purified RyR1 in complex with A8-35 (■). Linear fitting yielded Kd of 1.99 nM and Bmax of 60.4 pmol/mg of protein for RyR1/A8-35, and Kd of 41.27 nM and Bmax of 3.07 pmol/mg for RyR1/CHAPS and Kd of 2.54 nM and Bmax of 27.9 pmol/mg for SR membranes in high Ca^2+^ conditions (200μM Ca^2+^), indicating that the high-affinity binding site for ryanodine is retained in RyR1/Apol and similar to that of RyR1 embedded within the SR membrane.](ejtm-2015-1-4803-g004){#fig004}

###### 

**Detergent properties used in single-particle cryo-EM of ion channels.** The physical properties of used detergents including CMC, micelle size and molecular weight are important considerations when optimizing cryospecimen conditions.

  ----------------------------------------------------------------------------------------------------------------------------------------------------
  Detergent                                                       CMC (mM)    CMC (%w/v)   Micelle Size (Da)   Molecular Weight   Aggregation Number
  --------------------------------------------------------------- ----------- ------------ ------------------- ------------------ --------------------
  **CHAPS**\                                                      8           0.5          6,150               615                10
  3-\[(3-Cholamidopropyl)-dimethyl-ammonio\]-1-propanesulfonate                                                                   

  **Triton X-100**\                                               0.22-0.24   0.01-0.016   90,000              625                100-155
  polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether                                                                   

  **Digitonin**                                                   \<0.5       0.02         70,000              1,229              60

  **DDM**\                                                        0.17        0.0087       72,000              511                78-149
  n-Dodecyl- β-D-maltoside                                                                                                        

  **DM**\                                                         1.8         0.087        33,000              483                98
  n-Decyl-β-D-maltopyranosid                                                                                                      

  **OG**\                                                         23-25       0.67-0.73    8,000               292                27-100
  n-Octyl-β-D-glucoside                                                                                                           
  ----------------------------------------------------------------------------------------------------------------------------------------------------

###### 

**Attributes of membrane protein complexes determined by single-particle cryo-EM.** A summary of membrane protein structural studies and cryospecimen surfactants used. Listed for each macromolecular complex is the: molecular weight, EMDataBank \[EMD\] identification number, when available, author's reported resolution (Å) and surfactant type and amount present in cryospecimen.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Membrane Protein                                    M.W. (Mda)   EMDB ID        Resolution (Å)   Surfactant and amount reported in cryospecimen   Refs.                     
  --------------------------------------------------- ------------ -------------- ---------------- ------------------------------------------------ ------------ ------------ ------------
  ***Intracellular Ca^2+^ Release Channels***                                                                                                                                 

  RyR1                                                2.3          1274           14               CHAPS                                            0.40%        0.8-1        ^[@ref38]^

  1275                                                9.6          CHAPS          0.40%            0.8-1                                            ^[@ref37]^                

  5014                                                10.3         CHAPS          0.50%            1                                                ^[@ref40]^                

  1607, 1606                                          10.2         CHAPS          0.50%            1                                                ^[@ref41]^                

  IP~3~R1                                             1.3          ---            24               CHAPS                                            0.40%        0.8-1        ^[@ref83]^

  ---                                                 30           Triton X-100   0.15%            \>10                                             ^[@ref84]^                

  5278                                                10           CHAPS          0.40%            0.8-1                                            ^[@ref85]^                

  1061                                                20           CHAPS          1%               2                                                ^[@ref86]^                

  ***Voltage Gated Ca^2+^ Channel***                                                                                                                                          

  DHPR (Ca~V~1.1)                                     0.55         **---**        25               Digitonin                                        0.10%        5            ^[@ref87]^

  1069                                                25           Digitonin      0.10%            5                                                ^[@ref88]^                

  ***Transient Receptor Potential (TRP) Channels***                                                                                                                           

  TRPC3                                               0.388        **---**        15               DM                                               5 mM         2.7          ^[@ref89]^

  TRPV4                                               0.39         **---**        35               DDM                                              1 mM         5.9          ^[@ref90]^

  TRPV1                                               0.3          **---**        19               DM                                               0.1%         1.15         ^[@ref91]^

  TRPV1                                               0.3          5778           3.27             Apol                                             1:3\         ---          ^[@ref13]^
                                                                                                                                                    (w/w)                     

  TRPV1                                               0.3          5776, 5777     3.8\             Apol                                             1:3\         **---**      ^[@ref12]^
                                                                                  4.2                                                               (w/w)                     

  TRPV2                                               0.36         5688           13.6             decyl-MNG                                        0.006%       1.8          ^[@ref92]^

  TRPA1                                               0.525        5334           16               A8-35                                            1:2.3\       **---**      ^[@ref93]^
                                                                                                                                                    (w/w)                     

  ***Other Membrane Proteins***                                                                                                                                               

  K~V~AP-Fab                                          0.3          1094           10.5             DM                                               5mM          2.7          ^[@ref94]^

  MCA channel                                         0.2          2313           26               Ammonium perfluoro-octanoate                     4%           3.4          ^[@ref95]^

  GluR                                                0.37         2680\          10.4\            DDM                                              0.75 mM      4.4          ^[@ref62]^
                                                                   2684\          12.8\                                                                                       
                                                                   2685\          7.6\                                                                                        
                                                                   2686\          21.4\                                                                                       
                                                                   2687\          25.9\                                                                                       
                                                                   2688\          22.9\                                                                                       
                                                                   2689           16.4                                                                                        

  γ-Secretase                                         0.17         2677, 2678     4.5\             A8-35                                            1:3\         **---**      ^[@ref14]^
                                                                                  5.4                                                               (w/w)                     

  ATPase                                              0.6          5335           9.7              DDM                                              0.02%        2.3          ^[@ref96]^

  0.9                                                 5476         11             DDM              0.03%                                            3.4          ^[@ref97]^   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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